NCT02162485

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler Products and Seretide Diskus 50/500 µG/Inhalation; A Randomised, Open, Single Centre, Single Dose, Crossover Study in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 129 (actual)
• Sponsor: Orion Corporation, Orion Pharma · Industry
• Sex: All
• Age: 18 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purposes of this study is to compare the test products Salmeterol/fluticasone Easyhaler with marketed product Seretide Diskus in terms of the drug absorbed into the blood stream

Conditions

• Asthma

Interventions

Type	Name	Description
DRUG	Salmeterol/fluticasone Easyhaler
DRUG	Salmeterol/fluticasone Easyhaler with charcoal
DRUG	Seretide Diskus
DRUG	Seretide Diskus with charcoal

Timeline

• Start date: 2014-06-01
• Primary completion: 2015-09-01
• Completion: 2015-09-01
• First posted: 2014-06-12
• Last updated: 2015-09-29

Locations

1 site across 1 country: Finland